STAT1	B-protein
pathway	O
is	O
involved	O
in	O
activation	O
of	O
caprine	O
arthritis-encephalitis	B-DNA
virus	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
in	O
monocytes	B-cell_type
.	O

The	O
caprine	B-DNA
arthritis-encephalitis	I-DNA
virus	I-DNA
(	I-DNA
CAEV	I-DNA
)	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
is	O
activated	O
by	O
gamma	B-protein
interferon	I-protein
(	O
IFN-gamma	B-protein
)	O
in	O
promonocytic	B-cell_type
cells	I-cell_type
.	O

We	O
have	O
previously	O
shown	O
that	O
a	O
70-bp	B-DNA
element	I-DNA
is	O
necessary	O
and	O
sufficient	O
for	O
the	O
response	O
of	O
the	O
CAEV	B-DNA
LTR	I-DNA
to	O
this	O
cytokine	B-protein
.	O

At	O
the	O
5	B-DNA
'	I-DNA
end	I-DNA
,	O
this	O
70-bp	B-DNA
IFN-gamma	I-DNA
response	I-DNA
element	I-DNA
contains	O
sequence	O
similarity	O
to	O
the	O
gamma	B-DNA
activated	I-DNA
site	I-DNA
(	O
GAS	B-DNA
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
putative	O
GAS	B-DNA
element	I-DNA
in	O
the	O
CAEV	B-DNA
LTR	I-DNA
binds	O
specifically	O
to	O
a	O
cellular	B-protein
factor	I-protein
induced	O
by	O
IFN-gamma	B-protein
in	O
promonocytic	B-cell_type
cells	I-cell_type
.	O

Substitution	O
mutations	O
in	O
this	O
consensus	B-DNA
sequence	I-DNA
eliminate	O
binding	O
of	O
the	O
inducible	B-protein
factor	I-protein
.	O

The	O
GAS	B-DNA
element	I-DNA
from	O
the	O
70-bp	B-DNA
motif	I-DNA
is	O
sufficient	O
to	O
confer	O
responsiveness	O
to	O
IFN-gamma	B-protein
using	O
a	O
heterologous	O
minimal	O
promoter	O
.	O

Consistent	O
with	O
the	O
binding	O
data	O
,	O
the	O
same	O
mutations	O
in	O
the	O
GAS	B-DNA
element	I-DNA
eliminate	O
responsiveness	O
to	O
IFN-gamma	B-protein
in	O
the	O
context	O
of	O
both	O
a	O
functional	O
CAEV	B-DNA
LTR	I-DNA
and	O
a	O
heterologous	B-DNA
promoter	I-DNA
.	O

The	O
cellular	O
factor	O
that	O
binds	O
to	O
the	O
GAS	B-DNA
element	I-DNA
is	O
present	O
from	O
5	O
min	O
to	O
14	O
h	O
after	O
stimulation	O
with	O
IFN-gamma	B-protein
.	O

Binding	O
of	O
the	O
nuclear	O
factor	O
to	O
the	O
GAS	B-DNA
element	I-DNA
in	O
the	O
CAEV	B-DNA
LTR	I-DNA
is	O
inhibited	O
by	O
antibody	O
directed	O
against	O
STAT1	B-protein
(	O
p91/84	B-protein
)	O
.	O

Thus	O
,	O
the	O
GAS	O
sequence	O
in	O
the	O
CAEV	B-DNA
LTR	I-DNA
is	O
essential	O
for	O
the	O
response	O
to	O
IFN-gamma	B-protein
and	O
a	O
STAT1-like	B-protein
factor	I-protein
binds	O
to	O
this	O
site	O
.	O

The	O
STAT-1	O
signaling	O
pathway	O
provides	O
at	O
least	O
one	O
mechanism	O
for	O
activation	O
of	O
the	O
CAEV	B-DNA
LTR	I-DNA
by	O
IFN-gamma	B-protein
in	O
monocytes	B-cell_type
.	O

These	O
data	O
are	O
the	O
first	O
demonstration	O
of	O
a	O
role	O
for	O
a	O
STAT	B-protein
family	I-protein
member	I-protein
in	O
the	O
regulation	O
of	O
a	O
viral	B-DNA
promoter	I-DNA
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Jan.	NULL
1997	NULL
,	NULL
p.	NULL
771-777	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

1	NULL
STAT1	NULL
Pathway	NULL
Is	NULL
Involved	NULL
in	NULL
Activation	NULL
of	NULL
Caprine	NULL
Arthritis	NULL
Encephalitis	NULL
Virus	NULL
Long	NULL
Terminal	NULL
Repeat	NULL
in	NULL
Monocytes	NULL
TINA	NULL
SEPP	NULL
anp	NULL
SANDRA	NULL
E.	NULL
TONG-STARKSEN®*	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California-San	NULL
Francisco	NULL
and	NULL
Veterans	NULL
Administration	NULL
Medical	NULL
Center	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94121	NULL
Received	NULL
10	NULL
July	NULL
1996/Accepted	NULL
7	NULL
October	NULL
1996	NULL
The	NULL
caprine	NULL
arthritis-encephalitis	NULL
virus	NULL
(	NULL
CAEV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
is	NULL
activated	NULL
by	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
in	NULL
promonocytic	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
70-bp	NULL
element	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
response	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
to	NULL
this	NULL
cytokine	NULL
.	NULL

At	NULL
the	NULL
5	NULL
'	NULL
end	NULL
,	NULL
this	NULL
70-bp	NULL
IFN-y	NULL
response	NULL
element	NULL
contains	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
gamma	NULL
activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
putative	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
binds	NULL
specifically	NULL
to	NULL
a	NULL
cellular	NULL
factor	NULL
induced	NULL
by	NULL
IFN-y	NULL
in	NULL
promonocytic	NULL
cells	NULL
.	NULL

Substitution	NULL
mutations	NULL
in	NULL
this	NULL
consensus	NULL
sequence	NULL
eliminate	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
factor	NULL
.	NULL

The	NULL
GAS	NULL
element	NULL
from	NULL
the	NULL
70-bp	NULL
motif	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
using	NULL
a	NULL
heterologous	NULL
minimal	NULL
promoter	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
binding	NULL
data	NULL
,	NULL
the	NULL
same	NULL
mutations	NULL
in	NULL
the	NULL
GAS	NULL
element	NULL
eliminate	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
in	NULL
the	NULL
context	NULL
of	NULL
both	NULL
a	NULL
functional	NULL
CAEV	NULL
LTR	NULL
and	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

The	NULL
cellular	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
is	NULL
present	NULL
from	NULL
5	NULL
min	NULL
to	NULL
14	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
IFN-y	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
inhibited	NULL
by	NULL
antibody	NULL
directed	NULL
against	NULL
STAT1	NULL
(	NULL
p91/84	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
GAS	NULL
sequence	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
a	NULL
STAT1-like	NULL
factor	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
.	NULL

The	NULL
STAT-1	NULL
signaling	NULL
pathway	NULL
provides	NULL
at	NULL
least	NULL
one	NULL
mechanism	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
by	NULL
IFN-y	NULL
in	NULL
monocytes	NULL
.	NULL

These	NULL
data	NULL
are	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
a	NULL
role	NULL
for	NULL
a	NULL
STAT	NULL
family	NULL
member	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
viral	NULL
promoter	NULL
.	NULL

Caprine	NULL
arthritis-encephalitis	NULL
virus	NULL
(	NULL
CAEV	NULL
)	NULL
causes	NULL
a	NULL
sym-metric	NULL
,	NULL
peripheral	NULL
arthritis	NULL
in	NULL
infected	NULL
adult	NULL
goats	NULL
(	NULL
3	NULL
)	NULL
.	NULL

CAEV	NULL
belongs	NULL
to	NULL
the	NULL
group	NULL
of	NULL
nononcogenic	NULL
retroviruses	NULL
called	NULL
len-tiviruses	NULL
.	NULL

Other	NULL
members	NULL
of	NULL
the	NULL
group	NULL
include	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
,	NULL
HIV-2	NULL
,	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
,	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
,	NULL
feline	NULL
T-lymphotropic	NULL
virus	NULL
,	NULL
and	NULL
visna	NULL
virus	NULL
(	NULL
11	NULL
)	NULL
.	NULL

All	NULL
members	NULL
of	NULL
this	NULL
retrovirus	NULL
group	NULL
are	NULL
species	NULL
specific	NULL
,	NULL
have	NULL
tropism	NULL
for	NULL
the	NULL
cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
and	NULL
are	NULL
characterized	NULL
by	NULL
persistent	NULL
infections	NULL
in	NULL
vivo	NULL
.	NULL

Although	NULL
production	NULL
of	NULL
the	NULL
virus	NULL
is	NULL
restricted	NULL
in	NULL
infected	NULL
monocytes	NULL
,	NULL
differentiation	NULL
into	NULL
macrophages	NULL
results	NULL
in	NULL
increased	NULL
viral	NULL
expression	NULL
and	NULL
an	NULL
associated	NULL
inflammatory	NULL
response	NULL
.	NULL

In	NULL
vivo	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
tissue	NULL
macrophages	NULL
correlates	NULL
with	NULL
development	NULL
of	NULL
clinical	NULL
disease	NULL
,	NULL
such	NULL
as	NULL
inflammatory	NULL
arthritis	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Several	NULL
cellular	NULL
signalling	NULL
pathways	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lentiviral	NULL
transcription	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
is	NULL
regulated	NULL
in	NULL
monocytes	NULL
by	NULL
nuclear	NULL
factor	NULL
NF-kB	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
of	NULL
proto-oncogenes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
NF-kB	NULL
,	NULL
are	NULL
important	NULL
for	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
HIV-2	NULL
LTR	NULL
during	NULL
monocyte	NULL
differentiation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
FOS-JUN	NULL
heterodimer	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
for	NULL
activator	NULL
protein	NULL
(	NULL
AP-1	NULL
)	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
visna	NULL
virus	NULL
LTR	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
factors	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
have	NULL
not	NULL
been	NULL
characterized	NULL
.	NULL

Another	NULL
pathway	NULL
that	NULL
leads	NULL
to	NULL
differentiation	NULL
of	NULL
monocytes	NULL
is	NULL
initiated	NULL
by	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

This	NULL
cytokine	NULL
is	NULL
secreted	NULL
by	NULL
an	NULL
activated	NULL
subpopulation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
during	NULL
inflammatory	NULL
responses	NULL
to	NULL
viral	NULL
infection	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Signalling	NULL
through	NULL
the	NULL
IFN-y	NULL
receptor	NULL
leads	NULL
to	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
UCSF	NULL
Immunology/Arthritis	NULL
Section	NULL
(	NULL
111R	NULL
)	NULL
,	NULL
VAMC	NULL
,	NULL
4150	NULL
Clement	NULL
St.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94121	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
750-2104	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
750-6920	NULL
.	NULL

E-mail	NULL
:	NULL
TONG	NULL
SANDRA_	NULL
@	NULL
SANFRANCISCO.VA.GOV	NULL
.	NULL

TH	NULL
activation	NULL
of	NULL
a	NULL
distinct	NULL
pair	NULL
of	NULL
tyrosine	NULL
kinases	NULL
,	NULL
JAK1	NULL
and	NULL
JAK2	NULL
,	NULL
which	NULL
belong	NULL
to	NULL
the	NULL
Janus	NULL
kinase	NULL
family	NULL
(	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
an	NULL
additional	NULL
requirement	NULL
for	NULL
a	NULL
serine	NULL
kinase	NULL
and	NULL
serine	NULL
phosphorylation	NULL
for	NULL
maximal	NULL
activation	NULL
of	NULL
transcription	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
kinases	NULL
lead	NULL
to	NULL
phosphorylation	NULL
of	NULL
a	NULL
latent	NULL
cytoplasmic	NULL
protein	NULL
,	NULL
STAT1	NULL
(	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
)	NULL
.	NULL

Dimeric	NULL
phosphor-ylated	NULL
STAT1	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
gamma	NULL
activation	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
consensus	NULL
element	NULL
in	NULL
IFN-y-responsive	NULL
promoters	NULL
,	NULL
and	NULL
activates	NULL
IFN-y-dependent	NULL
transcription	NULL
of	NULL
different	NULL
cellular	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
22	NULL
,	NULL
25	NULL
)	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
in	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
activated	NULL
by	NULL
stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
IFN-y	NULL
.	NULL

A	NULL
70-bp	NULL
region	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
IFN-y	NULL
response	NULL
in	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
we	NULL
call	NULL
this	NULL
region	NULL
the	NULL
CAEV	NULL
70-bp	NULL
interferon	NULL
response	NULL
element	NULL
(	NULL
70-bp	NULL
IRE	NULL
)	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
agents	NULL
,	NULL
including	NULL
IFN-y	NULL
,	NULL
can	NULL
be	NULL
used	NULL
to	NULL
induce	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
a	NULL
more	NULL
mature	NULL
phenotype	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
U937	NULL
cells	NULL
induced	NULL
by	NULL
IFN-y	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
two	NULL
distinct	NULL
cellular	NULL
factors	NULL
to	NULL
the	NULL
GAS	NULL
sequence	NULL
:	NULL
IFN-y	NULL
activation	NULL
factor	NULL
(	NULL
STAT1	NULL
or	NULL
GAF	NULL
)	NULL
and	NULL
differentiation-induced	NULL
factor	NULL
(	NULL
DIF	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
CAEV	NULL
70-bp	NULL
IRE	NULL
contains	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
element	NULL
.	NULL

We	NULL
characterized	NULL
the	NULL
binding	NULL
of	NULL
cellular	NULL
factors	NULL
to	NULL
and	NULL
the	NULL
function	NULL
of	NULL
this	NULL
putative	NULL
GAS	NULL
element	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
a	NULL
GAS	NULL
consensus	NULL
site	NULL
in	NULL
the	NULL
70-bp	NULL
IRE	NULL
is	NULL
necessary	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
by	NULL
IFN-y	NULL
and	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
IFN-y	NULL
responsiveness	NULL
.	NULL

We	NULL
further	NULL
identify	NULL
the	NULL
cellular	NULL
factor	NULL
binding	NULL
to	NULL
this	NULL
sequence	NULL
as	NULL
STAT1	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
these	NULL
findings	NULL
are	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
regulation	NULL
of	NULL
a	NULL
viral	NULL
promoter	NULL
by	NULL
a	NULL
STAT	NULL
family	NULL
member	NULL
.	NULL

The	NULL
LTRs	NULL
of	NULL
two	NULL
different	NULL
isolates	NULL
of	NULL
CAEV	NULL
,	NULL
p1244	NULL
and	NULL
Co	NULL
,	NULL
contain	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
70-bp	NULL
IRE	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
these	NULL
LTRs	NULL
for	NULL
sequence	NULL
similarities	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
known	NULL
transcription	NULL
factors	NULL
revealed	NULL
that	NULL
the	NULL
772	NULL
NOTES	NULL
GAS	NULL
ah	NULL
ote	NULL
e	NULL
oe	NULL
ce	NULL
ne	NULL
we	NULL
te	NULL
tte	NULL
e	NULL
¥us3	NULL
J.	NULL
ViRoL	NULL
.	NULL

ACTGTGAGAC	NULL
ATGGGCTAAA	NULL
GAGGACTAAT	NULL
AACAAGCTAG	NULL
CCCAAATTCC	NULL
TGTAAATCAC	NULL
TTGGGGGGTT	NULL
-218	NULL
Co	NULL
ACTGTGAGAC	NULL
ATGGGGAAAA	NULL
GGGGACTGAG	NULL
AACAGACTAG	NULL
GCCCGATTCT	NULL
TGTAAATCAC	NULL
TTOTCCTGTT	NULL
-140	NULL
p1244	NULL
CAS	NULL
dhe	NULL
si	NULL
i	NULL
ch	NULL
oe	NULL
e	NULL
h	NULL
v	NULL
tt	NULL
ie	NULL
ATAAGAAAAG	NULL
CAAGTTCACT	NULL
ATGACAAAGC	NULL
AAAMATGTAAA	NULL
GGCCAAATTC	NULL
CTGTAAATCA	NULL
CTTGGGGGGT	NULL
-148	NULL
Co	NULL
ATAAGAAAAG	NULL
CAAGTICACT	NULL
ATGACAAAGC	NULL
AAAATGTAA-	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-.~	NULL
-101	NULL
p1244	NULL
TATAAGAAAA	NULL
GCAAGTTCAC	NULL
TATGACAAAG	NULL
CAAAATGTAA	NULL
CCCCAAGTOGC	NULL
TCACAGATGT	NULL
AACAGCTGAC	NULL
-78	NULL
Co	NULL
————————————————————————————————————————	NULL
CCoCARGTGC	NULL
TCACAAATGT	NULL
AACAGCTGAC	NULL
-71	NULL
p1	NULL
?	NULL

44	NULL
APA	NULL
ATATCAGCTG	NULL
ATGCTTGCTC	NULL
ATGCTGACAC	NULL
TGTAGCTCTG	NULL
AGCTGTATAT	NULL
AAGGAGAAGC	NULL
TT-GCTGCTT	NULL
-	NULL
$	NULL
Co	NULL
ACATCAGCTG	NULL
ATGCTTGCTC	NULL
ATGCTGACAA	NULL
TGTAGCTCTG	NULL
ACCTGTATAT	NULL
AAGGAGGAGC	NULL
TTTGCTGCTT	NULL
-1	NULL
pl244	NULL
mn	NULL
mm	NULL
mm	NULL
im	NULL
TATA	NULL
AP4	NULL
R	NULL
r—b	NULL
GCACTTCAGA	NULL
GTTCTAGGAG	NULL
AGTCCCTCCT	NULL
AGTCTCTCCT	NULL
CTCCGAGGAGS	NULL
CTACCGAGAC	NULL
CTCAAAATAA	NULL
+42	NULL
Co	NULL
GCACTTCAGA	NULL
GTTCTAGGAG	NULL
AGTTCCTCCT	NULL
AGTCTCTCCT	NULL
CTCCGAGGAG	NULL
GTACCGAGAC	NULL
CTCACAATAA	NULL
+70	NULL
pl244	NULL
tus	NULL
ASGAGTGATT	NULL
GCCTTACTGC	NULL
CGAGTGGAGA	NULL
GTGATTACTG	NULL
AGCGGCCGCGT	NULL
CTATCGGGAG	NULL
TCGTCCCTTA	NULL
+132	NULL
Co	NULL
AGGAGTGATT	NULL
GCCTTACTGC	NULL
CGAGTGCAGA	NULL
STGATTACTG	NULL
AGCGECCGCT	NULL
CTATCGGGAG	NULL
TCGTCCCTTA	NULL
+140	NULL
pla4ad	NULL
ATCTGTGCAA	NULL
TACCACGAGCG	NULL
GCTCTCGCAG	NULL
C	NULL
i163	NULL
Co	NULL
ATCTGTGCAA	NULL
TACCAGAGCG	NULL
GCTCTCGCA	NULL
+165	NULL
p1244	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
.	NULL

The	NULL
published	NULL
sequences	NULL
of	NULL
two	NULL
different	NULL
CAEV	NULL
strains	NULL
,	NULL
Co	NULL
and	NULL
p1244	NULL
,	NULL
are	NULL
shown	NULL
(	NULL
14	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Nucleotide	NULL
positions	NULL
are	NULL
numbered	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
sites	NULL
of	NULL
transcription	NULL
initiation	NULL
,	NULL
which	NULL
are	NULL
indicated	NULL
with	NULL
bent	NULL
arrows	NULL
.	NULL

Vertical	NULL
arrows	NULL
show	NULL
the	NULL
boundaries	NULL
of	NULL
the	NULL
U3	NULL
,	NULL
R	NULL
,	NULL
and	NULL
US	NULL
regions	NULL
.	NULL

Putative	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
,	NULL
AP-4	NULL
,	NULL
and	NULL
GAS	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
TATA	NULL
box	NULL
is	NULL
underlined	NULL
.	NULL

Dashes	NULL
in	NULL
strain	NULL
p1244	NULL
indicate	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
70-bp	NULL
sequence	NULL
motif	NULL
that	NULL
is	NULL
duplicated	NULL
in	NULL
strain	NULL
Co	NULL
.	NULL

The	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
regions	NULL
of	NULL
the	NULL
CAEV	NULL
70-bp	NULL
IRE	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

70-bp	NULL
IRE	NULL
contains	NULL
an	NULL
imperfect	NULL
palindrome	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
with	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
canonical	NULL
GAS	NULL
consensus	NULL
element	NULL
that	NULL
has	NULL
been	NULL
described	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
cellular	NULL
genes	NULL
regulated	NULL
by	NULL
IFN-y	NULL
(	NULL
5	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
cellular	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
70-bp	NULL
IRE	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
,	NULL
we	NULL
synthesized	NULL
double-stranded	NULL
DNA	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
(	NULL
positions	NULL
-175	NULL
to	NULL
-146	NULL
)	NULL
and	NULL
the	NULL
3	NULL
'	NULL
(	NULL
positions	NULL
-137	NULL
to	NULL
-108	NULL
)	NULL
regions	NULL
of	NULL
the	NULL
CAEV	NULL
70-bp	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
5	NULL
region	NULL
contains	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
element	NULL
,	NULL
while	NULL
the	NULL
3	NULL
``	NULL
region	NULL
is	NULL
divergent	NULL
.	NULL

We	NULL
performed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
which	NULL
undergoes	NULL
partial	NULL
differentiation	NULL
when	NULL
treated	NULL
with	NULL
IFN-y	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
nuclear	NULL
factors	NULL
induced	NULL
by	NULL
IFN-y	NULL
bound	NULL
to	NULL
the	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
CAEV	NULL
70-bp	NULL
IRE	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
were	NULL
not	NULL
present	NULL
in	NULL
unstimulated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Factors	NULL
induced	NULL
by	NULL
IFN-y	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
palindromic	NULL
IRE	NULL
(	NULL
pIRE	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
from	NULL
the	NULL
human	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
)	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
appeared	NULL
to	NULL
have	NULL
different	NULL
mobilities	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
mobility	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
different	NULL
but	NULL
antigenically	NULL
related	NULL
factors	NULL
to	NULL
these	NULL
consensus	NULL
sequences	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
different	NULL
mobilities	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
lengths	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
for	NULL
the	NULL
EMSAs	NULL
(	NULL
23	NULL
and	NULL
34	NULL
nucleotides	NULL
,	NULL
respec-tively	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
since	NULL
the	NULL
unbound	NULL
radiolabeled	NULL
ICAM-1	NULL
pIRE	NULL
and	NULL
the	NULL
CAEV	NULL
5	NULL
'	NULL
IRE	NULL
migrated	NULL
with	NULL
different	NULL
mobilities	NULL
in	NULL
nondenaturing	NULL
gels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
putative	NULL
GAS	NULL
element	NULL
in	NULL
binding	NULL
of	NULL
this	NULL
factor	NULL
,	NULL
we	NULL
disrupted	NULL
the	NULL
imperfect	NULL
palindrome	NULL
in	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
by	NULL
mutating	NULL
2	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
)	NULL
.	NULL

These	NULL
substitution	NULL
mutations	NULL
eliminated	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
induced	NULL
by	NULL
IFN-y	NULL
to	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
factors	NULL
induced	NULL
by	NULL
IFN-y	NULL
did	NULL
not	NULL
react	NULL
with	NULL
the	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
have	NULL
homology	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
element	NULL
.	NULL

An	NULL
additional	NULL
complex	NULL
,	NULL
observed	NULL
with	NULL
radiolabeled	NULL
oligonucleotides	NULL
,	NULL
was	NULL
present	NULL
in	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
cell	NULL
lysates	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
decreased	NULL
the	NULL
amount	NULL
of	NULL
this	NULL
complex	NULL
significantly	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
this	NULL
additional	NULL
complex	NULL
most	NULL
likely	NULL
represented	NULL
nonspecific	NULL
DNA-protein	NULL
interactions	NULL
.	NULL

Consequently	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
induced	NULL
by	NULL
IFN-y	NULL
bound	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
from	NULL
the	NULL
CAEV	NULL
LTR	NULL
and	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

These	NULL
factors	NULL
reacted	NULL
with	NULL
neither	NULL
the	NULL
mutated	NULL
GAS	NULL
oligonucleotide	NULL
nor	NULL
the	NULL
divergent	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
IFN-y	NULL
was	NULL
demonstrated	NULL
in	NULL
competition	NULL
experiments	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
5°	NULL
70-bp	NULL
IRE	NULL
,	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
,	NULL
the	NULL
ICAM	NULL
pIRE	NULL
,	NULL
or	NULL
the	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
were	NULL
added	NULL
in	NULL
30-fold	NULL
excess	NULL
Vou	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
NOTES	NULL
-	NULL
773	NULL
A	NULL
5	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
positions	NULL
-175	NULL
to	NULL
-146	NULL
)	NULL
AGCTTCAAATTCCTGTAAATCACTTGGGCGCGGTTA	NULL
m5	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
positions	NULL
-175	NULL
to	NULL
-146	NULL
)	NULL
AGCTTCAAATTCCTGTCACTCACTTGGGCCGGTTA	NULL
*	NULL
o*	NULL
3	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
positions	NULL
-137	NULL
to	NULL
-108	NULL
)	NULL
AGCTTGCAAGTTCACTATGACAAGCAAAATCTAA	NULL
ICAMIL	NULL
-	NULL
pIRE	NULL
AGCTTAGGTTTCCGGGAAAcCAC	NULL
{	NULL
&	NULL
w	NULL
-	NULL
44	NULL
&	NULL
B	NULL
#	NULL
¢	NULL
,	NULL
fe	NULL
©	NULL
&	NULL
£	NULL
,	NULL
&	NULL
v	NULL
[	NULL
P	NULL
32	NULL
]	NULL
labeled	NULL
g	NULL
é	NULL
?	NULL

é	NULL
?	NULL

<	NULL
5qu	NULL
4	NULL
&	NULL
(	NULL
5°	NULL
$	NULL
~§	NULL
Unlabeled	NULL
oligo	NULL
S	NULL
$	NULL
§	NULL
°	NULL
,	NULL
Unlabeled	NULL
oligos	NULL
@	NULL
gt	NULL
$	NULL
®	NULL
_	NULL
in	NULL
30x	NULL
excess	NULL
5	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
fragments	NULL
6	NULL
)	NULL
“	NULL
6	NULL
)	NULL
“	NULL
g	NULL
&	NULL
%	NULL
in	NULL
30x	NULL
excess	NULL
5	NULL
2	NULL
G	NULL
5	NULL
«	NULL
--	NULL
-7	NULL
[	NULL
P	NULL
32	NULL
]	NULL
labeled	NULL
C—|___|F	NULL
N'T	NULL
5°	NULL
70	NULL
bp	NULL
[	NULL
P	NULL
32	NULL
]	NULL
fragment	NULL
ICAM-1	NULL
pIRE	NULL
c	NULL
|__	NULL
IFN-y	NULL
induction	NULL
-	NULL
+o	NULL
-	NULL
+	NULL
®	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
b	NULL
s	NULL
[	NULL
(	NULL
*	NULL
]	NULL
N	NULL
1	NULL
2	NULL
3	NULL
4	NULL
L	NULL
3	NULL
3	NULL
.	NULL

4	NULL
.	NULL

5	NULL
.	NULL

6	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
coding	NULL
strands	NULL
of	NULL
duplex	NULL
oligonucleotides	NULL
synthesized	NULL
for	NULL
the	NULL
EMSAs	NULL
in	NULL
B	NULL
and	NULL
C	NULL
are	NULL
shown	NULL
.	NULL

GAS	NULL
consensus	NULL
sequences	NULL
are	NULL
in	NULL
boldface	NULL
.	NULL

HindIII	NULL
sites	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
enable	NULL
cloning	NULL
into	NULL
appropriate	NULL
vectors	NULL
.	NULL

The	NULL
2-bp	NULL
mutations	NULL
in	NULL
the	NULL
GAS	NULL
element	NULL
are	NULL
shown	NULL
with	NULL
asterisks	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-y	NULL
induces	NULL
a	NULL
nuclear	NULL
factor	NULL
in	NULL
promonocytic	NULL
cells	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
duplex	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
5	NULL
'	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
3	NULL
'	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
regions	NULL
of	NULL
the	NULL
CAEV	NULL
70-bp	NULL
IRE	NULL
(	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
and	NULL
3	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
a	NULL
mutant	NULL
5	NULL
'	NULL
70-bp	NULL
oligonucleotide	NULL
containing	NULL
two	NULL
mutations	NULL
in	NULL
the	NULL
CAEV	NULL
GAS	NULL
element	NULL
(	NULL
m5	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
,	NULL
in	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
a	NULL
pIRE	NULL
of	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
ICAM	NULL
pIRE	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
used	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
,	NULL
7	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Specificity	NULL
of	NULL
binding	NULL
demonstrated	NULL
by	NULL
competition	NULL
analyses	NULL
using	NULL
unlabeled	NULL
duplex	NULL
oligonucleotides	NULL
.	NULL

The	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
was	NULL
radiolabeled	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
U937	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
from	NULL
U937	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
(	NULL
lane	NULL
2	NULL
to	NULL
6	NULL
)	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
representing	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
ICAM	NULL
pIRE	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
the	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
were	NULL
added	NULL
in	NULL
30-fold	NULL
molar	NULL
excess	NULL
prior	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Complexes	NULL
were	NULL
resolved	NULL
as	NULL
described	NULL
above	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
similarity	NULL
of	NULL
the	NULL
complexes	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
and	NULL
the	NULL
CAEV	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
was	NULL
demonstrated	NULL
by	NULL
competition	NULL
analyses	NULL
.	NULL

The	NULL
ICAM-1	NULL
pIRE	NULL
was	NULL
radiolabeled	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
U937	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
from	NULL
the	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
unlabeled	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
added	NULL
in	NULL
30-fold	NULL
molar	NULL
excess	NULL
prior	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
resolved	NULL
as	NULL
described	NULL
above	NULL
.	NULL

as	NULL
specific	NULL
competitors	NULL
for	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
radiolabeled	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
in	NULL
a	NULL
specific	NULL
manner	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
hypothesis	NULL
,	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
and	NULL
the	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
binding	NULL
.	NULL

To	NULL
find	NULL
out	NULL
if	NULL
there	NULL
are	NULL
similarities	NULL
between	NULL
complexes	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
and	NULL
the	NULL
CAEV	NULL
GAS	NULL
,	NULL
we	NULL
additionally	NULL
performed	NULL
competition	NULL
experiments	NULL
with	NULL
the	NULL
unlabeled	NULL
CAEV	NULL
5	NULL
'	NULL
IRE	NULL
and	NULL
the	NULL
radiolabeled	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

The	NULL
promonocytic	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
ICAM-1	NULL
IRE	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
with	NULL
the	NULL
unlabeled	NULL
CAEV	NULL
5	NULL
'	NULL
IRE	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
unlabeled	NULL
CAEV	NULL
5	NULL
``	NULL
IRE	NULL
also	NULL
competes	NULL
with	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
promonocytic	NULL
cells	NULL
,	NULL
IFN-y	NULL
induces	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
in	NULL
a	NULL
specific	NULL
manner	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
and	NULL
this	NULL
factor	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
cellular	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

The	NULL
70-bp	NULL
IRE	NULL
from	NULL
the	NULL
CAEV	NULL
LTR	NULL
can	NULL
confer	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
(	NULL
i	NULL
)	NULL
promoter	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
transient	NULL
transfections	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
5	NULL
'	NULL
and/or	NULL
3	NULL
'	NULL
region	NULL
of	NULL
the	NULL
70-bp	NULL
IRE	NULL
motif	NULL
could	NULL
confer	NULL
responsiveness	NULL
to	NULL
the	NULL
ik	NULL
promoter	NULL
,	NULL
we	NULL
constructed	NULL
plasmids	NULL
containing	NULL
the	NULL
5°	NULL
70-bp	NULL
IRE	NULL
[	NULL
pCAEV	NULL
(	NULL
-175/-146	NULL
)	NULL
tkCAT	NULL
]	NULL
,	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
[	NULL
pCAEVm	NULL
(	NULL
-175/-146	NULL
)	NULL
tkCAT	NULL
]	NULL
,	NULL
and	NULL
the	NULL
3	NULL
``	NULL
70-bp	NULL
IRE	NULL
[	NULL
pCAEV	NULL
(	NULL
-137/-108	NULL
)	NULL
tkCAT	NULL
]	NULL
,	NULL
cloned	NULL
upstream	NULL
from	NULL
the	NULL
ik	NULL
promoter	NULL
and	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyl-	NULL
774	NULL
NOTES	NULL
J.	NULL
ViRor	NULL
.	NULL

GAS	NULL
Cas	NULL
*	NULL
|	NULL
__	NULL
R___	NULL
[	NULL
US	NULL
|	NULL
CAT	NULL
]	NULL
70	NULL
bp	NULL
IRE	NULL
|	NULL
44	NULL
a	NULL
570	NULL
bp	NULL
3	NULL
70	NULL
b	NULL
IRE	NULL
P	NULL
IRE	NULL
P	NULL
BASAL	NULL
ACTIVITY	NULL
A	NULL
TK	NULL
0.05	NULL
%	NULL
TK	NULL
FFF	NULL
0.89	NULL
%	NULL
5	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
-175/-146	NULL
)	NULL
*	NULL
%	NULL
TK	NULL
Z7	NULL
0.06	NULL
%	NULL
m5	NULL
'	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
-175/-146	NULL
)	NULL
TK	NULL
3	NULL
70	NULL
bp	NULL
IRE	NULL
(	NULL
-137/-108	NULL
)	NULL
TK	NULL
CAT	NULL
70	NULL
bp	NULL
[	NULL
RE	NULL
(	NULL
-189/-93	NULL
}	NULL
--	NULL
-	NULL
,	NULL
pCAEV	NULL
(	NULL
-189/+164	NULL
)	NULL
CAT	NULL
#	NULL
%	NULL
-L	NULL
pCAEV	NULL
m	NULL
(	NULL
-189/+164	NULL
)	NULL
CAT	NULL
pCAEYV	NULL
(	NULL
-107/+1644	NULL
)	NULL
CAT	NULL
0.08	NULL
%	NULL
0.93	NULL
%	NULL
FOLD	NULL
ACTIVATION	NULL
0.12	NULL
%	NULL
112	NULL
%	NULL
0.77	NULL
%	NULL
1.3	NULL
%	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
FOLD	NULL
ACTIVATION	NULL
10	NULL
12	NULL
-	NULL
14	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

The	NULL
GAS	NULL
sequence	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
required	NULL
for	NULL
IFN	NULL
response	NULL
.	NULL

A	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Duplicated	NULL
70-bp	NULL
IREs	NULL
are	NULL
indicated	NULL
by	NULL
striped	NULL
boxes	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
with	NULL
plasmids	NULL
containing	NULL
the	NULL
indicated	NULL
regions	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
upstream	NULL
from	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
#	NULL
minimal	NULL
promoter	NULL
(	NULL
A	NULL
)	NULL
or	NULL
from	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
basal	NULL
)	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
harvesting	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
basal	NULL
activity	NULL
was	NULL
calculated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Fold	NULL
activation	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
from	NULL
stimulated	NULL
cells	NULL
over	NULL
CAT	NULL
activity	NULL
from	NULL
unstimulated	NULL
cells	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
the	NULL
means	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
7	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cycloheximide	NULL
(	NULL
CXM	NULL
)	NULL
at	NULL
10	NULL
pg/ml	NULL
alone	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
prior	NULL
to	NULL
IFN-y	NULL
treatment	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
of	NULL
CAEV	NULL
(	NULL
wild-type	NULL
GAS	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

transferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
U937	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
21	NULL
)	NULL
and	NULL
stimulated	NULL
after	NULL
24	NULL
h	NULL
in	NULL
culture	NULL
with	NULL
IFN-y	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
200	NULL
U/ml	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
70-bp	NULL
IRE	NULL
and	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
resulted	NULL
in	NULL
increased	NULL
basal	NULL
activity	NULL
and	NULL
in	NULL
similar	NULL
responses	NULL
to	NULL
IFN-y	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
5.3-	NULL
and	NULL
7.8-fold	NULL
activation	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Since	NULL
comparable	NULL
levels	NULL
of	NULL
activation	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
(	NULL
2	NULL
)	NULL
,	NULL
the	NULL
70-bp	NULL
IRE	NULL
,	NULL
and	NULL
the	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
were	NULL
considered	NULL
sufficient	NULL
to	NULL
confer	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
basal	NULL
activities	NULL
and	NULL
the	NULL
responses	NULL
of	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
,	NULL
containing	NULL
the	NULL
mutated	NULL
GAS	NULL
element	NULL
,	NULL
and	NULL
of	NULL
the	NULL
3	NULL
'	NULL
70-bp	NULL
IRE	NULL
were	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
unresponsive	NULL
k	NULL
promoter	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
responsiveness	NULL
of	NULL
the	NULL
m5	NULL
'	NULL
70-bp	NULL
IRE	NULL
demonstrates	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
GAS	NULL
sequences	NULL
for	NULL
functional	NULL
activity	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
GAS	NULL
element	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
response	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
to	NULL
IFN-y	NULL
,	NULL
we	NULL
used	NULL
a	NULL
functional	NULL
CAEV	NULL
LTR	NULL
containing	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
70-bp	NULL
IRE	NULL
in	NULL
the	NULL
plasmid	NULL
pCAEV	NULL
(	NULL
-189/+164	NULL
)	NULL
CAT	NULL
.	NULL

This	NULL
plasmid	NULL
responds	NULL
to	NULL
IFN-y	NULL
with	NULL
the	NULL
same	NULL
efficiency	NULL
as	NULL
the	NULL
wild-type	NULL
LTR	NULL
of	NULL
strain	NULL
Co	NULL
(	NULL
26	NULL
)	NULL
,	NULL
positions	NULL
-287	NULL
to	NULL
+164	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
2-bp	NULL
substitution	NULL
mutations	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
in	NULL
the	NULL
GAS	NULL
element	NULL
were	NULL
introduced	NULL
into	NULL
pCAEV	NULL
(	NULL
-189/+164	NULL
)	NULL
CAT	NULL
by	NULL
using	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
(	NULL
Altered	NULL
Sites	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
the	NULL
functional	NULL
LTR	NULL
,	NULL
pCAEV	NULL
(	NULL
-189/+164	NULL
)	NULL
CAT	NULL
,	NULL
into	NULL
U937	NULL
cells	NULL
resulted	NULL
in	NULL
11.6-fold	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
GAS	NULL
element	NULL
pCAEVm	NULL
(	NULL
-189/	NULL
+164	NULL
)	NULL
CAT	NULL
partially	NULL
decreased	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
CAEV	NULL
promoter	NULL
and	NULL
eliminated	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

As	NULL
NOTES	NULL
-	NULL
775	NULL
C	NULL
IFN-y	NULL
Th	NULL
U	NULL
#	NULL
#	NULL
Ao	NULL
din	NULL
ld	NULL
1	NULL
2	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Inhibition	NULL
of	NULL
binding	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
by	NULL
an	NULL
anti-STAT1	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biochemicals	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
CAEV	NULL
5	NULL
'	NULL
70-bp	NULL
IRE	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
anti-STAT1	NULL
antibody	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
with	NULL
an	NULL
unrelated	NULL
control	NULL
antibody	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
duplex	NULL
oligonucleotide	NULL
.	NULL

a	NULL
negative	NULL
control	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
70-bp	NULL
IRE	NULL
in	NULL
the	NULL
construct	NULL
pCAEV	NULL
(	NULL
-107/+164	NULL
)	NULL
CAT	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
IFN-y	NULL
responsiveness	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
GAS	NULL
sequence	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
required	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
cellular	NULL
factors	NULL
induced	NULL
by	NULL
IFN-y	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
its	NULL
function	NULL
as	NULL
an	NULL
IRE	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
inducible	NULL
factor	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
element	NULL
appeared	NULL
at	NULL
5	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
was	NULL
still	NULL
present	NULL
at	NULL
11	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
disappeared	NULL
at	NULL
14	NULL
h	NULL
postinduction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
activation	NULL
complex	NULL
did	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
cycloheximide	NULL
treatment	NULL
prior	NULL
to	NULL
IFN-y	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Functional	NULL
GAS	NULL
elements	NULL
Gene	NULL
Species	NULL
Element	NULL
GBP	NULL
Human	NULL
ATTACTCTAAA	NULL
FoegRI	NULL
Human	NULL
TTTCCCAGAAA	NULL
ICSBP	NULL
Human	NULL
TTTCTCGGAAA	NULL
IRF-1	NULL
Human	NULL
TTTCCCCGAAA	NULL
IRF-1	NULL
Mouse	NULL
TTTCCCCGAAA	NULL
c-fos	NULL
Human	NULL
GTTCCCGTCAA	NULL
IFP-53	NULL
Human	NULL
ATTCTCAGAAA	NULL
Ly6E	NULL
Mouse	NULL
ATTCCTGTAAG	NULL
CDC23b	NULL
Human	NULL
TACCTGAGAAA	NULL
IgHe	NULL
Mouse	NULL
TTCACATGAAC	NULL
ICAM-1	NULL
Human	NULL
TTTCCCGGAAA	NULL
CAEV	NULL
LTR	NULL
Goat	NULL
ATTCCTGTAAA	NULL
Consensus	NULL
NTTNCNNNAA	NULL
776	NULL
NOTES	NULL
The	NULL
final	NULL
identification	NULL
of	NULL
the	NULL
cellular	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
was	NULL
provided	NULL
by	NULL
antibody	NULL
treatment	NULL
of	NULL
cell	NULL
lysates	NULL
prior	NULL
to	NULL
EMSA	NULL
.	NULL

Preincubation	NULL
of	NULL
U937	NULL
nuclear	NULL
extracts	NULL
with	NULL
an	NULL
anti-STAT1	NULL
polyclonal	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biochemicals	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
inhibited	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
CAEV	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
a	NULL
nonspecific	NULL
control	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
inhibition	NULL
was	NULL
STAT1	NULL
specific	NULL
.	NULL

The	NULL
STAT1	NULL
antibody	NULL
also	NULL
inhibited	NULL
complex	NULL
formation	NULL
between	NULL
the	NULL
factor	NULL
induced	NULL
by	NULL
IFN-y	NULL
and	NULL
the	NULL
radiolabeled	NULL
ICAM-1	NULL
pIRE	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
an	NULL
unrelated	NULL
protein	NULL
complex	NULL
to	NULL
the	NULL
radiolabeled	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
show	NULL
that	NULL
(	NULL
i	NULL
)	NULL
the	NULL
GAS	NULL
element	NULL
in	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
IFN-y	NULL
response	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
nuclear	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
CAEV	NULL
GAS	NULL
is	NULL
STAT1	NULL
or	NULL
a	NULL
STATi-like	NULL
factor	NULL
.	NULL

STAT1	NULL
belongs	NULL
to	NULL
the	NULL
STAT	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
interferons	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
IFN-y	NULL
induces	NULL
the	NULL
aggregation	NULL
of	NULL
the	NULL
receptor	NULL
complex	NULL
.	NULL

The	NULL
recruitment	NULL
of	NULL
Janus	NULL
kinases	NULL
JAK1	NULL
and	NULL
JAK2	NULL
results	NULL
in	NULL
the	NULL
reversible	NULL
phosphorylation	NULL
of	NULL
the	NULL
IFN-y	NULL
receptor	NULL
«	NULL
chain	NULL
,	NULL
which	NULL
creates	NULL
a	NULL
docking	NULL
site	NULL
for	NULL
the	NULL
sre	NULL
homology	NULL
2	NULL
domain	NULL
of	NULL
cytoplasmic	NULL
latent	NULL
STAT1	NULL
(	NULL
8	NULL
)	NULL
.	NULL

STAT1	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
,	NULL
dissociates	NULL
from	NULL
the	NULL
receptor	NULL
,	NULL
dimer-izes	NULL
,	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
the	NULL
nucleus	NULL
,	NULL
phosphor-ylated	NULL
STAT1	NULL
binds	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
element	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
IFN-inducible	NULL
genes	NULL
and	NULL
initiates	NULL
transcription	NULL
.	NULL

The	NULL
strict	NULL
requirement	NULL
of	NULL
STAT1	NULL
for	NULL
IFN-y	NULL
responsiveness	NULL
has	NULL
been	NULL
recently	NULL
demonstrated	NULL
in	NULL
STAT1-deficient	NULL
mice	NULL
(	NULL
6	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
CAEV	NULL
GAS	NULL
consensus	NULL
element	NULL
resembles	NULL
the	NULL
well-con-served	NULL
GAS	NULL
sequence	NULL
of	NULL
cellular	NULL
genes	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
show	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
these	NULL
cellular	NULL
genes	NULL
,	NULL
IFN-y	NULL
can	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
viral	NULL
genes	NULL
through	NULL
the	NULL
GAS	NULL
element	NULL
.	NULL

The	NULL
anti-STAT1	NULL
serum	NULL
used	NULL
in	NULL
our	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
is	NULL
STAT1	NULL
specific	NULL
and	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
688	NULL
to	NULL
700	NULL
in	NULL
the	NULL
carboxy	NULL
domain	NULL
.	NULL

It	NULL
has	NULL
been	NULL
used	NULL
to	NULL
discriminate	NULL
between	NULL
different	NULL
members	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
,	NULL
such	NULL
as	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
STATS	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
STAT1	NULL
is	NULL
unique	NULL
and	NULL
is	NULL
not	NULL
related	NULL
to	NULL
those	NULL
of	NULL
the	NULL
other	NULL
STAT	NULL
's	NULL
(	NULL
7	NULL
)	NULL
.	NULL

This	NULL
serum	NULL
recognizes	NULL
two	NULL
naturally	NULL
occurring	NULL
splice	NULL
variants	NULL
,	NULL
STAT1	NULL
«	NULL
and	NULL
STAT1IB	NULL
(	NULL
p91	NULL
and	NULL
p84	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

STAT1a	NULL
«	NULL
contains	NULL
38	NULL
additional	NULL
C-terminal	NULL
amino	NULL
acids	NULL
.	NULL

Although	NULL
STAT1B	NULL
becomes	NULL
phos-phorylated	NULL
and	NULL
can	NULL
bind	NULL
to	NULL
DNA	NULL
,	NULL
it	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
after	NULL
induction	NULL
with	NULL
IFN-y	NULL
(	NULL
5	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
CAEV	NULL
GAS	NULL
binding	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
STAT1	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
results	NULL
demonstrating	NULL
the	NULL
requirement	NULL
of	NULL
CAEV	NULL
GAS	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
CAEV	NULL
GAS	NULL
binding	NULL
protein	NULL
is	NULL
STAT1a	NULL
«	NULL
and	NULL
that	NULL
STAT1	NULL
is	NULL
at	NULL
least	NULL
one	NULL
pathway	NULL
by	NULL
which	NULL
the	NULL
CAEV	NULL
LTR	NULL
is	NULL
activated	NULL
by	NULL
IFN-y	NULL
.	NULL

Another	NULL
factor	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
consensus	NULL
element	NULL
is	NULL
the	NULL
differentiation-induced	NULL
factor	NULL
DIF	NULL
(	NULL
7	NULL
)	NULL
.	NULL

DIF	NULL
and	NULL
STAT1	NULL
are	NULL
clearly	NULL
distinct	NULL
molecules	NULL
,	NULL
although	NULL
both	NULL
are	NULL
induced	NULL
in	NULL
U937	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
treatment	NULL
.	NULL

DIF	NULL
has	NULL
a	NULL
slower	NULL
mobility	NULL
on	NULL
EMSA	NULL
than	NULL
STAT1	NULL
,	NULL
binds	NULL
to	NULL
selected	NULL
GAS	NULL
elements	NULL
,	NULL
and	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
p91	NULL
(	NULL
STAT1	NULL
)	NULL
abolish	NULL
the	NULL
binding	NULL
of	NULL
STAT1	NULL
to	NULL
GAS	NULL
but	NULL
do	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
DIF	NULL
to	NULL
GAS	NULL
elements	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
sequence	NULL
in	NULL
our	NULL
experiments	NULL
was	NULL
STAT1	NULL
and	NULL
not	NULL
DIF	NULL
,	NULL
since	NULL
antibodies	NULL
to	NULL
STAT1	NULL
abolish	NULL
binding	NULL
to	NULL
the	NULL
CAEV	NULL
GAS	NULL
element	NULL
,	NULL
and	NULL
the	NULL
factor	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

Our	NULL
demonstration	NULL
of	NULL
STAT1	NULL
involvement	NULL
in	NULL
upregulation	NULL
of	NULL
the	NULL
CAEV	NULL
LTR	NULL
provides	NULL
an	NULL
interesting	NULL
insight	NULL
into	NULL
the	NULL
multiple	NULL
roles	NULL
of	NULL
IFN-y	NULL
,	NULL
initially	NULL
identified	NULL
due	NULL
to	NULL
its	NULL
antiviral	NULL
effects	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IFN-y	NULL
as	NULL
an	NULL
antiviral	NULL
agent	NULL
is	NULL
documented	NULL
by	NULL
three	NULL
types	NULL
of	NULL
clinical	NULL
observations	NULL
:	NULL
(	NULL
i	NULL
)	NULL
IFN	NULL
production	NULL
correlates	NULL
with	NULL
natural	NULL
recovery	NULL
in	NULL
many	NULL
viral	NULL
infections	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
inhibition	NULL
of	NULL
IFN	NULL
production	NULL
or	NULL
action	NULL
enhances	NULL
the	NULL
severity	NULL
of	NULL
infection	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
IFN	NULL
treatment	NULL
protects	NULL
against	NULL
viral	NULL
infection	NULL
(	NULL
1	NULL
)	NULL
.	NULL

One	NULL
mechanism	NULL
for	NULL
the	NULL
antiviral	NULL
effect	NULL
of	NULL
IFN-y	NULL
is	NULL
a	NULL
specific	NULL
inhibitory	NULL
effect	NULL
on	NULL
viral	NULL
promoters	NULL
such	NULL
as	NULL
the	NULL
murine	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
immediate-early	NULL
promoter	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
murine	NULL
CMV	NULL
promoter	NULL
correlates	NULL
with	NULL
inhibition	NULL
of	NULL
viral	NULL
replication	NULL
by	NULL
IFN-y	NULL
in	NULL
infected	NULL
fibroblasts	NULL
.	NULL

Alternatively	NULL
,	NULL
IFN-y	NULL
can	NULL
enhance	NULL
replication	NULL
of	NULL
rat	NULL
CMV	NULL
in	NULL
macrophages	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
IFN-y	NULL
pathway	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
the	NULL
development	NULL
and	NULL
progression	NULL
of	NULL
murine	NULL
AIDS	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
effects	NULL
of	NULL
IFN-y	NULL
on	NULL
viral	NULL
replication	NULL
in	NULL
vivo	NULL
are	NULL
variable	NULL
.	NULL

CAEV	NULL
infection	NULL
of	NULL
immature	NULL
monocytes	NULL
results	NULL
in	NULL
low	NULL
levels	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

We	NULL
propose	NULL
a	NULL
model	NULL
in	NULL
which	NULL
subsequent	NULL
infection	NULL
of	NULL
the	NULL
host	NULL
with	NULL
other	NULL
viruses	NULL
stimulates	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
the	NULL
Th1	NULL
subset	NULL
of	NULL
T-helper	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
infected	NULL
monocytes	NULL
by	NULL
IFN-y	NULL
activates	NULL
not	NULL
only	NULL
cellular	NULL
genes	NULL
but	NULL
also	NULL
the	NULL
CAEV	NULL
promoter	NULL
through	NULL
the	NULL
STAT1	NULL
pathway	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
CAEV	NULL
promoter	NULL
results	NULL
in	NULL
increased	NULL
viral	NULL
replication	NULL
,	NULL
which	NULL
could	NULL
stimulate	NULL
additional	NULL
host	NULL
immune	NULL
responses	NULL
.	NULL

The	NULL
host	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
produce	NULL
the	NULL
clinical	NULL
disease	NULL
that	NULL
occurs	NULL
in	NULL
CAEV-infected	NULL
goats	NULL
.	NULL

Whether	NULL
the	NULL
STAT1	NULL
pathway	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
and	NULL
disease	NULL
development	NULL
in	NULL
the	NULL
infected	NULL
host	NULL
will	NULL
be	NULL
addressed	NULL
in	NULL
future	NULL
experiments	NULL
.	NULL

We	NULL
thank	NULL
Janice	NULL
Clements	NULL
and	NULL
B.	NULL
Matija	NULL
Peterlin	NULL
for	NULL
plasmid	NULL
con-structions	NULL
;	NULL
Daniel	NULL
Rengstorff	NULL
and	NULL
Amador	NULL
Pagtakhan	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
T.	NULL
S.	NULL
Benedict	NULL
Yen	NULL
,	NULL
W.	NULL
Seaman	NULL
,	NULL
and	NULL
B.	NULL
Matija	NULL
Peterlin	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
P6OAR20684	NULL
Multipurpose	NULL
Arthritis	NULL
and	NULL
Musculoskeletal	NULL
Diseases	NULL
Center	NULL
grant	NULL
and	NULL
AI28735	NULL
)	NULL
,	NULL
the	NULL
VA	NULL
Merit	NULL
Review	NULL
Board	NULL
,	NULL
and	NULL
the	NULL
Northern	NULL
California	NULL
Arthritis	NULL
Foundation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baron	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
F.	NULL
Dianzani	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
interferons	NULL
:	NULL
a	NULL
biological	NULL
system	NULL
with	NULL
therapeutic	NULL
potential	NULL
in	NULL
viral	NULL
infections	NULL
.	NULL

Antiviral	NULL
Res	NULL
.	NULL

24:97-110	NULL
.	NULL

2	NULL
.	NULL

Caldehoven	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Coffer	NULL
,	NULL
Y.	NULL
Juping	NULL
,	NULL
A	NULL
.	NULL

Van	NULL
de	NULL
Stolpe	NULL
,	NULL
F.	NULL
Horn	NULL
,	NULL
W.	NULL
Kruijer	NULL
,	NULL
and	NULL
P.	NULL
Van	NULL
der	NULL
Saag	NULL
.	NULL

1994	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
human	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
promoter	NULL
by	NULL
interleukin-6	NULL
and	NULL
interferon-y	NULL
involves	NULL
binding	NULL
of	NULL
distinct	NULL
factors	NULL
to	NULL
a	NULL
palindromic	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:21146-21154	NULL
.	NULL

3	NULL
.	NULL

Crawford	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
D.	NULL
S.	NULL
Adams	NULL
,	NULL
W.	NULL
P.	NULL
Cheevers	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Cork	NULL
.	NULL

1980	NULL
.	NULL

Chronic	NULL
arthritis	NULL
in	NULL
goats	NULL
caused	NULL
by	NULL
a	NULL
retrovirus	NULL
.	NULL

Science	NULL
207:997-999	NULL
.	NULL

4	NULL
.	NULL

Dalton	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
S.	NULL
Pitts-Meck	NULL
,	NULL
S.	NULL
Keshav	NULL
,	NULL
I.	NULL
S.	NULL
Figari	NULL
,	NULL
A.	NULL
Bradley	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Stewart	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
defects	NULL
of	NULL
immune	NULL
cell	NULL
function	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
interferon-y	NULL
genes	NULL
.	NULL

Science	NULL
259:1739-1742	NULL
.	NULL

5	NULL
.	NULL

Darnell	NULL
,	NULL
D.	NULL
K.	NULL
J.	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1994	NULL
.	NULL

Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
264:1415-1421	NULL
.	NULL

6	NULL
.	NULL

Durbin	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
Hackenmiller	NULL
,	NULL
M.	NULL
C.	NULL
Simon	NULL
,	NULL
and	NULL
D.	NULL
Levy	NULL
.	NULL

1996	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
Stat1	NULL
gene	NULL
results	NULL
in	NULL
compromised	NULL
innate	NULL
immunity	NULL
to	NULL
viral	NULL
disease	NULL
.	NULL

Cell	NULL
84:443-450	NULL
.	NULL

7	NULL
.	NULL

Eilers	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Baccarini	NULL
,	NULL
F.	NULL
Horn	NULL
,	NULL
H.	NULL
R.	NULL
A.	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
T.	NULL
Decker	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
factor	NULL
induced	NULL
by	NULL
differentiation	NULL
signals	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
macrophage	NULL
lincage	NULL
binds	NULL
to	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1364-1373	NULL
.	NULL

8	NULL
.	NULL

Greenlund	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
M.	NULL
O.	NULL
Morales	NULL
,	NULL
B.	NULL
L.	NULL
Viviano	NULL
,	NULL
H.	NULL
Yan	NULL
,	NULL
J.	NULL
Krolewski	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Schreiber	NULL
.	NULL

1995	NULL
.	NULL

Stat	NULL
recruitment	NULL
by	NULL
tyrosine-phosphorylated	NULL
cytokine	NULL
receptors	NULL
:	NULL
an	NULL
ordered	NULL
reversible	NULL
affinity-driven	NULL
process	NULL
.	NULL

Immunity	NULL
2:677-687	NULL
.	NULL

9	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
339:70-73	NULL
.	NULL

10	NULL
.	NULL

Haagmans	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
P.	NULL
H.	NULL
Van	NULL
der	NULL
Meide	NULL
,	NULL
F.	NULL
S.	NULL
Stals	NULL
,	NULL
A.	NULL
J.	NULL
M.	NULL
Van	NULL
den	NULL
Eertwegh	NULL
,	NULL
E.	NULL
Claassen	NULL
,	NULL
C.	NULL
A.	NULL
Bruggeman	NULL
,	NULL
M.	NULL
C.	NULL
Horzinek	NULL
,	NULL
and	NULL
V.	NULL
E.	NULL
C.	NULL
Schijns	NULL
.	NULL

1994	NULL
.	NULL

Suppression	NULL
of	NULL
rat	NULL
cytomegalovirus	NULL
replication	NULL
by	NULL
antibodies	NULL
against	NULL
gamma	NULL
interferon	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:2305-2312	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Haase	NULL
,	NULL
A.	NULL
T.	NULL
1986	NULL
.	NULL

Pathogenesis	NULL
of	NULL
lentivirus	NULL
infections	NULL
.	NULL

Nature	NULL
322:130-136	NULL
.	NULL

Harms	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Splitter	NULL
.	NULL

1995	NULL
.	NULL

Interfcron-y	NULL
inhibits	NULL
transgene	NULL
expression	NULL
driven	NULL
by	NULL
SV	NULL
40	NULL
or	NULL
CMV	NULL
promoters	NULL
but	NULL
augments	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
mammalian	NULL
MHC	NULL
I	NULL
promoter	NULL
.	NULL

Hum	NULL
.	NULL

Gene	NULL
Ther	NULL
.	NULL

61291-1297	NULL
.	NULL

Harris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
Ralph	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL	NULL
60	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

37:407-422	NULL
.	NULL

Hess	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
M.	NULL
Pyper	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Clements	NULL
.	NULL

1986	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
caprine	NULL
arthritis-encephalitis	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

60:385-393	NULL
.	NULL

Hilfinger	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
N.	NULL
Clark	NULL
,	NULL
M.	NULL
Smith	NULL
,	NULL
K.	NULL
Robinson	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Markovitz	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
in	NULL
monocytes	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:4448-4453	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
N.	NULL
1996	NULL
.	NULL

STATs	NULL
:	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
84:331-334	NULL
.	NULL

Lairmore	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
G.	NULL
Y.	NULL
Akita	NULL
,	NULL
H.	NULL
I.	NULL
Russell	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
DeMartin	NULL
.	NULL

1987	NULL
.	NULL

Replication	NULL
and	NULL
cytopathic	NULL
effects	NULL
of	NULL
ovine	NULL
lentivirus	NULL
strains	NULL
in	NULL
alveolar	NULL
macrophages	NULL
correlate	NULL
with	NULL
in	NULL
vivo	NULL
pathogenecity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:4038-4042	NULL
.	NULL

Meraz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
J.	NULL
M.	NULL
White	NULL
,	NULL
K.	NULL
C.	NULL
F.	NULL
Shechan	NULL
,	NULL
E.	NULL
A.	NULL
Bach	NULL
,	NULL
S.	NULL
J.	NULL
Rodig	NULL
,	NULL
A.	NULL
S.	NULL
Dighe	NULL
,	NULL
D.	NULL
H.	NULL
Kaplan	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
K.	NULL
Carver-Moore	NULL
,	NULL
R.	NULL
N.	NULL
Dubois	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
Statl	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431-442	NULL
.	NULL

Murray	NULL
,	NULL
H.	NULL
W.	NULL
1988	NULL
.	NULL

Interferon-gamma	NULL
,	NULL
the	NULL
activated	NULL
macrophage	NULL
,	NULL
and	NULL
host	NULL
defense	NULL
against	NULL
microbial	NULL
challenge	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

108:595-608	NULL
.	NULL

Prieto	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Eklund	NULL
,	NULL
and	NULL
M.	NULL
Patarroyo	NULL
.	NULL

1994	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
integrins	NULL
and	NULL
other	NULL
adhesion	NULL
molecules	NULL
during	NULL
differentiation	NULL
of	NULL
monocytes	NULL
into	NULL
macrophages	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

156:191-211	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

NOTES	NULL
-	NULL
777	NULL
Queen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1983	NULL
.	NULL

Immunoglobulin	NULL
gene	NULL
transcription	NULL
is	NULL
activated	NULL
by	NULL
downstream	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
33:741-748	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypep-tide	NULL
ligands	NULL
:	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621-651	NULL
.	NULL

Sherman	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Yaniv	NULL
,	NULL
H.	NULL
Lichtman-Pleban	NULL
,	NULL
S.	NULL
R.	NULL
Tronick	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Gazit	NULL
.	NULL

1989	NULL
.	NULL

Analysis	NULL
of	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
and	NULL
caprine	NULL
arthritis-encephalitis	NULL
virus	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

Virology	NULL
63	NULL
:	NULL
4925-4931	NULL
.	NULL

Shih	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
L.	NULL
M.	NULL
Carruth	NULL
,	NULL
M.	NULL
Anderson	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Clements	NULL
.	NULL

1992	NULL
.	NULL

Involvement	NULL
of	NULL
FOS	NULL
and	NULL
JUN	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
visna	NULL
virus	NULL
gene	NULL
expression	NULL
in	NULL
macrophages	NULL
through	NULL
an	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
viral	NULL
LTR	NULL
.	NULL

Virology	NULL
190:84-91.	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
C.-A	NULL
.	NULL

Siegrist	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
B.	NULL
Lisowska-Grospierre	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
IFN-y	NULL
mediated	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

Science	NULL
265:106-109	NULL
.	NULL

Tong	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
T.	NULL
Sepp	NULL
,	NULL
and	NULL
J.	NULL
Pagtakhan	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
caprine	NULL
arthritis-encephalitis	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
by	NULL
gamma	NULL
interferon	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70	NULL
:	NULL
595-599	NULL
.	NULL

Tsukada	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
R.	NULL
Waterman	NULL
,	NULL
Y.	NULL
Koyama	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
Auron	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
STAT	NULL
-like	NULL
factor	NULL
mediates	NULL
lipopolysaccharide	NULL
,	NULL
interleukin	NULL
1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
signaling	NULL
and	NULL
recognizes	NULL
a	NULL
gamma	NULL
interferon	NULL
activation	NULL
site-like	NULL
clement	NULL
in	NULL
the	NULL
ILIB	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2183-2194	NULL
.	NULL

Uehara	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Yasumichi	NULL
,	NULL
F.	NULL
Numata	NULL
,	NULL
M.	NULL
Makino	NULL
,	NULL
L.	NULL
Howard	NULL
,	NULL
T.	NULL
Mizuochi	NULL
,	NULL
and	NULL
K.	NULL
Takatsu	NULL
,	NULL
1994	NULL
.	NULL

An	NULL
IFN-y	NULL
dependent	NULL
pathway	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
pathogenesis	NULL
of	NULL
murine	NULL
immunodeficiency	NULL
syndrome	NULL
induced	NULL
by	NULL
LP-BM5S	NULL
murine	NULL
leukemia	NULL
virus	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

61937-1947	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Statl	NULL
and	NULL
Stat3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphoryla-tion	NULL
.	NULL

Cell	NULL
82:241-250	NULL
.	NULL

